238 related articles for article (PubMed ID: 23867799)
1. Gadolinium contrast agent-induced CD163+ ferroportin+ osteogenic cells in nephrogenic systemic fibrosis.
Swaminathan S; Bose C; Shah SV; Hall KA; Hiatt KM
Am J Pathol; 2013 Sep; 183(3):796-807. PubMed ID: 23867799
[TBL] [Abstract][Full Text] [Related]
2. Evidence Suggesting a Role of Iron in a Mouse Model of Nephrogenic Systemic Fibrosis.
Bose C; Megyesi JK; Shah SV; Hiatt KM; Hall KA; Karaduta O; Swaminathan S
PLoS One; 2015; 10(8):e0136563. PubMed ID: 26305890
[TBL] [Abstract][Full Text] [Related]
3. Centrality of bone marrow in the severity of gadolinium-based contrast-induced systemic fibrosis.
Drel VR; Tan C; Barnes JL; Gorin Y; Lee DY; Wagner B
FASEB J; 2016 Sep; 30(9):3026-38. PubMed ID: 27221979
[TBL] [Abstract][Full Text] [Related]
4. Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?
Boyd AS; Sanyal S; Abraham JL
J Am Acad Dermatol; 2010 Feb; 62(2):337-42. PubMed ID: 19939504
[TBL] [Abstract][Full Text] [Related]
5. Persistent activation of dermal fibroblasts from patients with gadolinium-associated nephrogenic systemic fibrosis.
Piera-Velazquez S; Louneva N; Fertala J; Wermuth PJ; Del Galdo F; Jimenez SA
Ann Rheum Dis; 2010 Nov; 69(11):2017-23. PubMed ID: 20570839
[TBL] [Abstract][Full Text] [Related]
6. Nephrogenic systemic fibrosis: evidence for oxidative stress and bone marrow-derived fibrocytes in skin, liver, and heart lesions using a 5/6 nephrectomy rodent model.
Wagner B; Tan C; Barnes JL; Ahuja S; Davis TL; Gorin Y; Jimenez F
Am J Pathol; 2012 Dec; 181(6):1941-52. PubMed ID: 23041060
[TBL] [Abstract][Full Text] [Related]
7. Pathomechanisms of nephrogenic systemic fibrosis: new insights.
Gupta A; Shamseddin MK; Khaira A
Clin Exp Dermatol; 2011 Oct; 36(7):763-8. PubMed ID: 21790732
[TBL] [Abstract][Full Text] [Related]
8. Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure.
Bernstein EJ; Schmidt-Lauber C; Kay J
Best Pract Res Clin Rheumatol; 2012 Aug; 26(4):489-503. PubMed ID: 23040363
[TBL] [Abstract][Full Text] [Related]
9. Nephrogenic systemic fibrosis in Denmark--a nationwide investigation.
Elmholdt TR; Olesen AB; Jørgensen B; Kvist S; Skov L; Thomsen HS; Marckmann P; Pedersen M
PLoS One; 2013; 8(12):e82037. PubMed ID: 24349178
[TBL] [Abstract][Full Text] [Related]
10. Contemporary applications and limitations of magnetic resonance imaging contrast materials.
Natalin RA; Prince MR; Grossman ME; Silvers D; Landman J
J Urol; 2010 Jan; 183(1):27-33. PubMed ID: 19913804
[TBL] [Abstract][Full Text] [Related]
11. Type of MRI contrast, tissue gadolinium, and fibrosis.
Do C; Barnes JL; Tan C; Wagner B
Am J Physiol Renal Physiol; 2014 Oct; 307(7):F844-55. PubMed ID: 25100280
[TBL] [Abstract][Full Text] [Related]
12. Gadolinium compounds signaling through TLR4 and TLR7 in normal human macrophages: establishment of a proinflammatory phenotype and implications for the pathogenesis of nephrogenic systemic fibrosis.
Wermuth PJ; Jimenez SA
J Immunol; 2012 Jul; 189(1):318-27. PubMed ID: 22649203
[TBL] [Abstract][Full Text] [Related]
13. [Nephrogenic systemic fibrosis and use of MR contrast media].
Christiansen RE; Sviland L; Sekse I; Svarstad E
Tidsskr Nor Laegeforen; 2009 Jan; 129(3):180-2. PubMed ID: 19180161
[TBL] [Abstract][Full Text] [Related]
14. Induction of the expression of profibrotic cytokines and growth factors in normal human peripheral blood monocytes by gadolinium contrast agents.
Wermuth PJ; Del Galdo F; Jiménez SA
Arthritis Rheum; 2009 May; 60(5):1508-18. PubMed ID: 19404939
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium-associated nephrogenic systemic fibrosis.
Schlaudecker JD; Bernheisel CR
Am Fam Physician; 2009 Oct; 80(7):711-4. PubMed ID: 19817341
[TBL] [Abstract][Full Text] [Related]
16. Gadolinium-Induced Fibrosis.
Todd DJ; Kay J
Annu Rev Med; 2016; 67():273-91. PubMed ID: 26768242
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil elastase in the development of nephrogenic systemic fibrosis (NSF)-like skin lesion in renal failure mouse model.
Kartamihardja AAP; Amalia SN; Sekiguchi A; Bhattarai A; Taketomi-Takahashi A; Motegi SI; Koyama H; Tsushima Y
PLoS One; 2021; 16(10):e0259211. PubMed ID: 34705860
[TBL] [Abstract][Full Text] [Related]
18. Gadolinium-associated nephrogenic systemic fibrosis in a 9-year-old boy.
Foss C; Smith JK; Ortiz L; Hanevold C; Davis L
Pediatr Dermatol; 2009; 26(5):579-82. PubMed ID: 19840315
[TBL] [Abstract][Full Text] [Related]
19. Overlapping roles of NADPH oxidase 4 for diabetic and gadolinium-based contrast agent-induced systemic fibrosis.
Bruno F; DeAguero J; Do C; Lee DY; Tan C; Escobar GP; Wagner B
Am J Physiol Renal Physiol; 2021 Apr; 320(4):F617-F627. PubMed ID: 33615889
[TBL] [Abstract][Full Text] [Related]
20. Gadolinium toxicity: Iron and ferroportin as central targets.
Swaminathan S
Magn Reson Imaging; 2016 Dec; 34(10):1373-1376. PubMed ID: 27580520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
